Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Scroll down to content

Posts

Posted on 7 January 20207 January 2020

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
  • FDA Approves Genentech’s Tecentriq plus Cotellic and Zelboraf for People With Advanced Melanoma
  • FDA Approves Xeglyze (abametapir) Lotion for the Treatment of Head Lice
  • FDA Approves Tecartus (brexucabtagene autoleucel) as the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma

RSS Pharma Manufacturing News

  • MYR Pharmaceuticals receives conditional marketing authorisation by European Commission for HEPCLUDEX
  • ReViral secures FDA fast track status for sisunatovir to treat severe RSV infection
  • FDA approves IND for PSC’s stem cell therapy candidate for Covid-19

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • A 4-point guide to rethinking your digital health care strategy
  • Virtual Care: Innovations and Efficiencies for Clinicians, Patients and Administrators on the Microsoft Platform
  • Spotlight Series: Artificial Intelligence and Machine Learning
  • Rapid Deployment, Multi-Cloud Strategies Growing Among Healthcare Organizations
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok